151 related articles for article (PubMed ID: 21715562)
1. Afobazole modulates neuronal response to ischemia and acidosis via activation of sigma-1 receptors.
Cuevas J; Behensky A; Deng W; Katnik C
J Pharmacol Exp Ther; 2011 Oct; 339(1):152-60. PubMed ID: 21715562
[TBL] [Abstract][Full Text] [Related]
2. Afobazole modulates microglial function via activation of both sigma-1 and sigma-2 receptors.
Cuevas J; Rodriguez A; Behensky A; Katnik C
J Pharmacol Exp Ther; 2011 Oct; 339(1):161-72. PubMed ID: 21715561
[TBL] [Abstract][Full Text] [Related]
3. Sigma-1 receptor activation prevents intracellular calcium dysregulation in cortical neurons during in vitro ischemia.
Katnik C; Guerrero WR; Pennypacker KR; Herrera Y; Cuevas J
J Pharmacol Exp Ther; 2006 Dec; 319(3):1355-65. PubMed ID: 16988055
[TBL] [Abstract][Full Text] [Related]
4. Afobazole activation of σ-1 receptors modulates neuronal responses to amyloid-β25-35.
Behensky AA; Yasny IE; Shuster AM; Seredenin SB; Petrov AV; Cuevas J
J Pharmacol Exp Ther; 2013 Nov; 347(2):468-77. PubMed ID: 24006338
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of sigma receptors with afobazole blocks activation of microglia and reduces toxicity caused by amyloid-β25-35.
Behensky AA; Yasny IE; Shuster AM; Seredenin SB; Petrov AV; Cuevas J
J Pharmacol Exp Ther; 2013 Nov; 347(2):458-67. PubMed ID: 24006337
[TBL] [Abstract][Full Text] [Related]
6. Activation of σ1 and σ2 receptors by afobazole increases glial cell survival and prevents glial cell activation and nitrosative stress after ischemic stroke.
Katnik C; Garcia A; Behensky AA; Yasny IE; Shuster AM; Seredenin SB; Petrov AV; Cuevas J
J Neurochem; 2016 Nov; 139(3):497-509. PubMed ID: 27488244
[TBL] [Abstract][Full Text] [Related]
7. Treatment with afobazole at delayed time points following ischemic stroke improves long-term functional and histological outcomes.
Katnik C; Garcia A; Behensky AA; Yasny IE; Shuster AM; Seredenin SB; Petrov AV; Seifu S; McAleer J; Willing A; Cuevas J
Neurobiol Dis; 2014 Feb; 62():354-64. PubMed ID: 24141021
[TBL] [Abstract][Full Text] [Related]
8. sigma-1 receptor modulation of acid-sensing ion channel a (ASIC1a) and ASIC1a-induced Ca2+ influx in rat cortical neurons.
Herrera Y; Katnik C; Rodriguez JD; Hall AA; Willing A; Pennypacker KR; Cuevas J
J Pharmacol Exp Ther; 2008 Nov; 327(2):491-502. PubMed ID: 18723775
[TBL] [Abstract][Full Text] [Related]
9. Chaperone Sigma1R mediates the neuroprotective action of afobazole in the 6-OHDA model of Parkinson's disease.
Voronin MV; Kadnikov IA; Voronkov DN; Seredenin SB
Sci Rep; 2019 Nov; 9(1):17020. PubMed ID: 31745133
[TBL] [Abstract][Full Text] [Related]
10. [Effect of afobazole on the accumulation of free radical oxidation products and the catalase activity in rats with cerebral ischemia].
Silkina IV; Zenina TA; Seredenin SB; Mirzoian RS
Eksp Klin Farmakol; 2006; 69(4):47-50. PubMed ID: 16995439
[TBL] [Abstract][Full Text] [Related]
11. [Afobazole influence on antinociceptive properties of morphine].
Kolik LG; Zhukov VN; Seredenin SB
Eksp Klin Farmakol; 2009; 72(1):22-3. PubMed ID: 19334506
[TBL] [Abstract][Full Text] [Related]
12. Deferred Administration of Afobazole Induces Sigma1R-Dependent Restoration of Striatal Dopamine Content in a Mouse Model of Parkinson's Disease.
Kadnikov IA; Verbovaya ER; Voronkov DN; Voronin MV; Seredenin SB
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076300
[TBL] [Abstract][Full Text] [Related]
13. sigma Receptor activation blocks potassium channels and depresses neuroexcitability in rat intracardiac neurons.
Zhang H; Cuevas J
J Pharmacol Exp Ther; 2005 Jun; 313(3):1387-96. PubMed ID: 15764734
[TBL] [Abstract][Full Text] [Related]
14. [Afobazole decreases motor side effects induced by haloperidol].
Seredenin SB; Garibova TA; Kuznetsova AL; Voronin MV; Iarkova MA; Voronina TA
Eksp Klin Farmakol; 2009; 72(1):15-8. PubMed ID: 19334504
[TBL] [Abstract][Full Text] [Related]
15. [Neuroreceptor mechanisms of the afobazole effect].
Seredenin SB; Voronin MV
Eksp Klin Farmakol; 2009; 72(1):3-11. PubMed ID: 19334502
[TBL] [Abstract][Full Text] [Related]
16. Interaction of afobazole with sigma1-receptors.
Seredenin SB; Antipova TA; Voronin MV; Kurchashova SY; Kuimov AN
Bull Exp Biol Med; 2009 Jul; 148(1):42-4. PubMed ID: 19902093
[TBL] [Abstract][Full Text] [Related]
17. ASIC1a channels are activated by endogenous protons during ischemia and contribute to synergistic potentiation of intracellular Ca(2+) overload during ischemia and acidosis.
Mari Y; Katnik C; Cuevas J
Cell Calcium; 2010 Jul; 48(1):70-82. PubMed ID: 20678793
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Cytoprotective Properties of Afobazole in Streptozotocin Model of Diabetes.
Ivanov SV; Ostrovskaya RU; Sorokina AV; Seredenin SB
Bull Exp Biol Med; 2020 Oct; 169(6):783-786. PubMed ID: 33098515
[TBL] [Abstract][Full Text] [Related]
19. SA4503, a sigma-1 receptor agonist, prevents cultured cortical neurons from oxidative stress-induced cell death via suppression of MAPK pathway activation and glutamate receptor expression.
Tuerxun T; Numakawa T; Adachi N; Kumamaru E; Kitazawa H; Kudo M; Kunugi H
Neurosci Lett; 2010 Jan; 469(3):303-8. PubMed ID: 20025928
[TBL] [Abstract][Full Text] [Related]
20. In vitro evaluation of guanidine analogs as sigma receptor ligands for potential anti-stroke therapeutics.
Behensky AA; Cortes-Salva M; Seminerio MJ; Matsumoto RR; Antilla JC; Cuevas J
J Pharmacol Exp Ther; 2013 Jan; 344(1):155-66. PubMed ID: 23065135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
